Premaitha Health is a molecular diagnostics company employing next generation DNA analysis technology to develop, manufacture and sell molecular diagnostic products intended to have a major beneficial impact on human health. Premaitha is responsible for the development, manufacture and commercialisation of their diagnostic products and works with partners to provide the instrument platforms needed
by its laboratory customers. Premaitha Health was established in 2013 and is located on Manchester Science Park, Manchester, UK
Premaitha’s first product is the IONA® test which is the first non-invasive in vitro diagnostic product for prenatal screening. The IONA® test is a complete diagnostic system that is simple and standardised, enabling Premaitha’s clinical laboratory customers to perform the test in their laboratory, using existing clinical workflow. A fundamental element of the IONA® test is exceptional technical support and customer service. The IONA® test is non-invasive, simple and accurate, and is designed to encourage the broad uptake of the technology allowing all pregnant women accurate and safe information about their pregnancy. Premaitha is built upon a wealth of diagnostic expertise with an experienced management team, scientific and technical excellence and class leading quality management and development systems. Currently focused in the area of non-invasive prenatal tests (NIPT), Premaitha aims to extend its portfolio to cover oncology, personalised medicine and other areas of human health.
